United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Technology Industry News SentinelOne achieves profitability milestone in Q3 FY2025 as revenue and ARR surge SentinelOne (NYSE: S) has delivered a robust performance for the third quarter of fiscal year 2025, reporting a… byPallavi MadhirajuDecember 5, 2024